Designing an evidence based community pharmacy service specification for a pharmacogenomic testing service

Rendell, Tim, Barnett, Julie, Scott, Sion and Wright, David (2022) Designing an evidence based community pharmacy service specification for a pharmacogenomic testing service. International Journal of Clinical Pharmacy, 44 (6). pp. 1406-1416. ISSN 2210-7703

Microsoft Word (Scott_etal_Designing_an_evidence-based_community_pharmacy_service_specification_2022_IJoCP_Final) - Published Version Available under License Creative Commons Attribution. Download (199kB)

Abstract

Background: Pharmacogenomics is a novel arena of medicine that uses patients’ Deoxyribonucleic Acid to support pharmacists and prescribers selecting the most appropriate medicine for patients.  Aim: To review and validate a service specification for a pharmacogenomics testing service.  Method: Consensus methods (Delphi method and the Nominal Group Technique) were deployed. A consensus panel comprising of pharmacists, prescribers and patients was convened to participate in the co-design process. Panel members were first surveyed to obtain their views on Behaviour Change Techniques identified as necessary for the service in a previous study. Following this, a workshop was convened to discuss, agree and confirm details for the service specification and recommend strategies for operationalisation. Outputs from the workshop were used to inform a final version of the service specification.  Results: From the consensus panel (pharmacists (n = 6), general practitioners (n = 3) and patients (n = 3)), strategies for operationalisation of nine Behaviour Change Techniques were agreed as being required. In addition, several unique and innovative strategies for implementation of the community pharmacy service were identified and included in the service specification.  Conclusion: The research shows that to encourage community pharmacist engagement in providing a pharmacogenomic testing service and prescriber acceptance of recommendations for any changes to patients’ prescriptions, a multi-professional launch event is required. To agree communication strategies and professional boundaries, training in clinical decision making and patient support materials are required as is guidance on how to deliver the service in a standardised manner. Finally, healthcare professionals would be reassured by the provision of an expert help-line for any complex patients.

Item Type:	Article
Uncontrolled Keywords:	behaviour change techniques,community pharmacy,pharmacogenomics,pharmacy,toxicology,pharmacology,pharmaceutical science,pharmacology (medical) ,/dk/atira/pure/subjectarea/asjc/3600/3611
Faculty \ School:	Faculty of Medicine and Health Sciences > School of Health Sciences Faculty of Science > School of Chemistry, Pharmacy and Pharmacology
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	16 Jan 2026 10:30
Last Modified:	16 Jan 2026 10:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/101625
DOI:	10.1007/s11096-022-01483-8

Downloads

Actions (login required)

View Item